SSY Group Limited (HKG:2005)

Market Cap	7.16B -20.0%
Revenue (ttm)	4.17B -27.8%
Net Income	470.64M -55.6%
EPS	0.16 -55.2%
Shares Out	2.89B
PE Ratio	15.42
Forward PE	12.38
Dividend	0.08 (3.23%)
Ex-Dividend Date	May 20, 2026

Volume	2,580,000
Open	2.355
Previous Close	2.445
Day's Range	2.355 - 2.480
52-Week Range	2.010 - 3.400
Beta	0.52
Analysts	Strong Buy
Price Target	3.64 (+47.07%)
Earnings Date	Aug 26, 2026

About SSY Group

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 5,472
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2005

Financial Performance

In 2025, SSY Group's revenue was 4.17 billion, a decrease of -27.85% compared to the previous year's 5.77 billion. Earnings were 470.64 million, a decrease of -55.65%.

Analyst Summary

According to 2 analysts, the average rating for 2005 stock is "Strong Buy." The 12-month stock price target is $3.64, which is an increase of 47.07% from the latest price.

Price Target

$3.64

(47.07% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error